摘要
目的:研究解整合素金属蛋白酶-17(ADAM17)的特异性高效抑制剂,以控制炎症及其相关过程。方法:筛选确定ADAM17基因RNAi有效靶序列,合成靶序列的Oligo DNA,与慢病毒载体(GV115)连接,PCR筛选阳性克隆,测序鉴定。通过Western Blot检测细胞ADAM17的蛋白表达。用重组慢病毒转导脂多糖(LPS)刺激的U937细胞,观察重组慢病毒在蛋白质水平上对ADAM17的表达和活性的影响。结果:成功构建了ADAM17RNAi重组慢病毒,并能显著抑制ADAM17的蛋白表达,减少sTNF-α分泌。结论:ADAM17RNAi重组慢病毒降低了sTNF-α的分泌,对炎症有明显的抑制作用,为抗炎药物的设计和改造提供了新的依据和方法。
Objective:To construct a lentiviral vector of RNA interference(RNAi)of ADAM17-gene and study an effective inhibitor of ADAM17 to control inflammation and related processes.Methods:A lentivirus vector(GV115)expressing shRNA targeting the ADAM17 gene was constructed.ADAM17 expression was assessed by Western Blot.After stimulated with LPS,the U937 cells were transfected with the lentivirus.The sTNF-αwas assessed by ELISA and the mTNF-αwas assessed by Western Blot.Results:The ADAM17 shRNA lentivirus reduced ADAM17 expression,and prevented TNF-αmaturation in U937 cells.In summary,this study successfully constructed a shRNA lentivirus vector targeting the ADAM17 gene that had clear in vitro effects of TNF-αprocessing in response to an LPS challenge.Conclusion:These results may help inform the design and improvement of drugs designed to inhibit the function of ADAM17,and suggest a novel mean of controlling inflammation and related processes.
作者
何兵
李小鸥
庹虎
张明霞
万俊华
HE Bing;LI Xiao'ou;TUO Hu;ZHANG Mingxia;WANG Junhua(Dept.of Pediatrics,Renmin Hospital of Wuhan University,Whuan 430060,Chin)
出处
《武汉大学学报(医学版)》
CAS
2018年第5期725-728,共4页
Medical Journal of Wuhan University
基金
国家自然科学基金资助项目(编号:81000094)
湖北省自然科学基金资助项目(编号:2012FB04418)